advertisement
Clinical Ophthalmology 10
Showing records 1 to 10 | Display all abstracts in Clinical Ophthalmology50463 Long-term outcomes of a pseudo 360-degree trabeculotomy ab externo technique for congenital glaucoma at children's medical center
Saltzmann RM; Reinecke S; Lin X; Cavanagh HD; Whitson JT
Clinical Ophthalmology 2012; 6: 689-698
50636 Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification
Parke DW; Sisk RA; Houston SK; Murray TG
Clinical Ophthalmology 2012; 6: 925-931
50357 Glaucomatous optic nerve head alterations in patients with chronic heart failure
Meira-Freitas D; Melo LA; Almeida-Freitas DB; Paranhos A
Clinical Ophthalmology 2012; 6: 623-629
50465 Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Pfennigsdorf S; Ramez O; von Kistowski G; Mä,der B; Eschstruth P; Frobö,se M; Thelen U; Spraul C; Schnober D; Cooper H; Laube T
Clinical Ophthalmology 2012; 6: 739-746
50462 Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
Ermiş SS
Clinical Ophthalmology 2012; 6: 673-678
50541 Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension
Pacella F; Turchetti P; Santamaria V; Impallara D; Smaldone G; Brillante C; Librando A; Damiano A; Pecori-Giraldi J; Pacella E
Clinical Ophthalmology 2012; 6: 811-815
50306 Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
Inoue K; Okayama R; Higa R; Wakakura M; Tomita G
Clinical Ophthalmology 2012; 6: 607-612
50528 Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
Inoue K; Fujimoto T; Higa R; Moriyama R; Kohmoto H; Nagumo H; Wakakura M; Tomita G
Clinical Ophthalmology 2012; 6: 771-775
50464 Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
Costa VP; Moreira H; Paolera MD; de Moraes Silva MR
Clinical Ophthalmology 2012; 6: 699-706
50637 Surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients
Salim S; Du H; Boonyaleephan S; Wan J
Clinical Ophthalmology 2012; 6: 955-962
